Plasma Levels of Matrix Metalloproteinase-2 (MMP-2) and Tissue Inhibitors of Metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as Noninvasive Markers of Liver Disease in Chronic Hepatitis C Comparison Using ROC Analysis
- 1 January 1999
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 44 (3), 624-630
- https://doi.org/10.1023/a:1026630129025
Abstract
As chronic liver disease progresses, animbalance occurs between synthesis and breakdown ofextracellular matrix (ECM). Matrix metalloproteinases(MMPs) are involved in degrading ECM while...Keywords
This publication has 28 references indexed in Scilit:
- Serum levels of tissue inhibitor of metalloproteinases‐2 and of precursor form of matrix metalloproteinase‐2 in patients with liver diseaseLiver International, 1997
- Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseasesJournal of Hepatology, 1996
- Relationship of aminotransferases to liver histological status in chronic hepatitis C.1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Clinical Outcomes after Transfusion-Associated Hepatitis CNew England Journal of Medicine, 1995
- Epidemiology of Hepatitis C in the EastSeminars in Liver Disease, 1995
- Clinical evaluation of serum tissue inhibitor of metalloproteinases‐1 levels in patients with liver diseasesJournal of Gastroenterology and Hepatology, 1993
- Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinomaClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug usersThe Lancet, 1990
- The use of relative operating characteristic (ROC) curves in test performance evaluation.1986